Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Xếp hạng trong cổ phiếu #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Giá cổ phiếu
$44.60
Vốn hóa thị trường
$108.62B
Thay đổi (1 ngày)
-1.63%
Thay đổi (1 năm)
-21.62%
Quốc gia
FR
Giao dịch Sanofi (SNY)

Danh mục

Tỷ lệ P/S của Sanofi (SNY)
Tỷ lệ P/S vào March 2026 TTM: 1.58
Theo các báo cáo tài chính và giá cổ phiếu mới nhất của Sanofi, tỷ lệ P/S hiện tại (TTM) là 1.58. Vào cuối năm 2024, công ty có P/S là 2.65.
Lịch sử tỷ lệ P/S của Sanofi từ 2000 đến 2026
Tỷ lệ P/S vào cuối mỗi năm
Năm Tỷ lệ P/S Thay đổi
2026 (TTM) 1.58 -31.45%
2025 2.31 -12.64%
2024 2.65 8.53%
2023 2.44 -1.50%
2022 2.48 -12.51%
2021 2.83 7.27%
2020 2.64 -11.31%
2019 2.98 12.55%
2018 2.64 6.21%
2017 2.49 -12.68%
2016 2.85 -3.17%
2015 2.95 -5.34%
2014 3.11 -4.59%
2013 3.26 24.47%
2012 2.62 22.45%
2011 2.14 9.73%
2010 1.95 -16.66%
2009 2.34 13.41%
2008 2.06 -28.87%
2007 2.90 -10.07%
2006 3.22 -7.11%
2005 3.47 -2.51%
2004 3.56 -31.81%
2003 5.22 -8.16%
2002 5.69 -39.51%
2001 9.40 8.55%
2000 8.66 0.00%
Tỷ lệ P/S của các công ty tương tự hoặc đối thủ cạnh tranh
Công ty Tỷ lệ P/S Chênh lệch Tỷ lệ P/S Quốc gia
14.26 800.32%
US
4.96 213.28%
GB
6.18 290.20%
US
6.35 301.05%
US
5.18 226.89%
CH